Briacell TherapeuticsBCTX
13F holders, Q3 2025 (September 30)13holders
1famous investor
$10.97avg. 13F price*
At the end of Q3 2025, 13 institutions reported holding Briacell Therapeutics Corp. (BCTX) in their 13F filings. The largest holders were Citadel Advisors ($122K), Federation des caisses Desjardins du Quebec ($10K) and Morgan Stanley ($1K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Briacell Therapeutics Corp.
- CUSIP
- 107930307
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $122K |
| Exits | 0 | $0 |
Ownership 13 holders
| Citadel Advisors | 0.00% | New | 11,055 | $122K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +158.6% | 905 | $10K |
| Morgan Stanley | 0.00% | Add +8669.2% | 114 | $1K |
| Royal Bank of Canada | 0.00% | Reduce -6.5% | 100 | $1K |
| SBI Securities Co., Ltd. | 0.00% | Add +33.3% | 80 | $880 |
| Group One Trading LLC | 0.00% | Reduce -1.1% | 70 | $770 |
| UBS Group AG | 0.00% | Reduce -95.8% | 64 | $704 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 19 | $238 |
| Allworth Financial LP | 0.00% | No change | 7 | $77 |
| HHM Wealth Advisors, LLC | 0.00% | Reduce -9.1% | 6 | $66 |
| Osaic Holdings, Inc. | 0.00% | New | 6 | $46 |
| Wells Fargo & Company | 0.00% | Reduce -68.8% | 1 | $11 |
| FNY Investment Advisers, LLC | 0.00% | No change | 10 | $0 |
"% of holder's portfolio" is BCTX's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.